These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 536276)

  • 41. Combined use of radioprotective and radiosensitizing drugs in experimental radiotherapy.
    Yuhas JM; Yurconic M; Kligerman MM; West G; Peterson DF
    Radiat Res; 1977 May; 70(2):433-43. PubMed ID: 193145
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of mouse hepatitis virus infection on combination therapy of P388 leukemia with cyclophosphamide and pyrimidinones.
    Li LH; DeKoning TF; Nicholas JA; Kramer GD; Wilson D; Wallace TL; Collins MJ
    Lab Anim Sci; 1987 Feb; 37(1):41-4. PubMed ID: 3035278
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanism of resistance to the oncolytic C-nucleoside 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC-286193).
    Jayaram HN; Cooney DA; Glazer RI; Dion RL; Johns DG
    Biochem Pharmacol; 1982 Aug; 31(15):2557-60. PubMed ID: 7126269
    [No Abstract]   [Full Text] [Related]  

  • 44. Phase I study of aziridinylbenzoquinone (AZQ, NSC 182986) in children with cancer.
    Tan CT; Hancock CH; Mondora A; Hoffman NW
    Cancer Res; 1984 Feb; 44(2):831-5. PubMed ID: 6692381
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isomer-dependent cytostatic activity of bis(1-aziridinyl)cyclophosphazenes.
    van der Huizen AA; Wilting T; van de Grampel JC; Lelieveld P; van der Meer-Kalverkamp A; Lamberts HB; Mulder NH
    J Med Chem; 1986 Aug; 29(8):1341-5. PubMed ID: 3735303
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carcinostatic action of 2-cyanaziridines against a sarcoma in rats.
    Bicker U; Fuhse P
    Exp Pathol (Jena); 1975; 10(5-6):279-84. PubMed ID: 1233288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of the immunomodulant 2-cyanaziridine derivative BM 41.332 on adjuvant arthritis in the rat.
    Bicker U
    Arzneimittelforschung; 1982; 32(7):746-52. PubMed ID: 6889876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
    Tsuruo T; Oh-Hara T; Sudo Y; Naito M
    Anticancer Res; 1993; 13(2):357-61. PubMed ID: 8517647
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effectiveness of combined action of vitamins A, E and C and cyclophosphane or adriamycin on growth of transplanted tumors in mice].
    Mosienko VS; Khasanova LT; Sukolinskiĭ VN; Morozkina TS
    Eksp Onkol; 1990; 12(3):55-7. PubMed ID: 2344827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models.
    Mirabelli CK; Johnson RK; Sung CM; Faucette L; Muirhead K; Crooke ST
    Cancer Res; 1985 Jan; 45(1):32-9. PubMed ID: 3917372
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antitumor effect of methylene blue in vivo].
    Lai BT
    Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):98-100. PubMed ID: 2806052
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative stereochemistry in the aziridine ring openings of N-methylmitomycin A and 7-methoxy-1,2-(N-methylaziridino)mitosene.
    Cheng L; Remers WA
    J Med Chem; 1977 Jun; 20(6):767-70. PubMed ID: 874953
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.
    Ganapathi R; Grabowski D
    Cancer Res; 1983 Aug; 43(8):3696-9. PubMed ID: 6861140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Use of the Soviet preparations, fotrin and imifos, in erythremia].
    Petrov KIa; Buglaev AP
    Probl Gematol Pereliv Krovi; 1980 Aug; 25(8):14-6. PubMed ID: 7413620
    [No Abstract]   [Full Text] [Related]  

  • 55. [In vitro evaluation of the chemosensitivity of an experimental murine leukemia rendered resistant in vivo to adriamycin].
    Lepri E; Menconi E; Barzi AM
    Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1369-75. PubMed ID: 6477749
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
    Avramis VI; Plunkett W
    Cancer Res; 1982 Jul; 42(7):2587-91. PubMed ID: 7083151
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cytostatic action of N-ethyl-13-dihydrorubomycin on the cells of various tumor strains].
    Volkolupova OP
    Antibiotiki; 1984 Jun; 29(6):435-7. PubMed ID: 6548103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and testing of quinone-based bis(2,2-dimethyl-1-aziridinyl)phosphinyl carbamates as radiation-potentiating antitumor agents.
    Zhang SF; Earle J; MacDiarmid J; Bardos TJ
    J Med Chem; 1988 Jun; 31(6):1240-4. PubMed ID: 3373492
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antitumor activity of TZT-1027, a novel dolastatin 10 derivative.
    Kobayashi M; Natsume T; Tamaoki S; Watanabe J; Asano H; Mikami T; Miyasaka K; Miyazaki K; Gondo M; Sakakibara K; Tsukagoshi S
    Jpn J Cancer Res; 1997 Mar; 88(3):316-27. PubMed ID: 9140117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Some structure-activity relationships for bactobolin analogs in the treatment of mouse leukemia P388.
    Munakata T; Okumoto T
    Chem Pharm Bull (Tokyo); 1981 Mar; 29(3):891-4. PubMed ID: 7249163
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.